Victor William Nitti

Title(s)Professor, Urology
SchoolMedicine
vCardDownload vCard
    Other Positions
    Title(s)Professor, Obstetrics and Gynecology


    Collapse Overview 
    Collapse Overview
    Dr. Victor Nitti holds the Shlomo Raz, M.D., Chair in Urology.

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Melatonin and melatonin receptor agonists in the treatment of nocturia: A systematic review. Neurourol Urodyn. 2024 Mar 08. Burke CA, Nitti VW, Stothers L. PMID: 38456646.
      View in: PubMed   Mentions:    Fields:    
    2. Bladder outlet obstruction in women: Advanced evaluation. Neurourol Urodyn. 2024 Jan 30. Lec PM, Nitti VW. PMID: 38289332.
      View in: PubMed   Mentions:    Fields:    
    3. Outcomes of women diagnosed with primary bladder neck obstruction based on video urodynamic criteria. Neurourol Urodyn. 2023 Dec 11. Drain A, Volkin D, Rosenblum N, Brucker BM, Nitti VW. PMID: 38078683.
      View in: PubMed   Mentions:    Fields:    
    4. Treatment of neurogenic detrusor overactivity and overactive bladder with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine (Baltimore). 2023 Jul 01; 102(S1):e32377. Nitti V, Haag-Molkenteller C, Kennelly M, Chancellor M, Jenkins B, Schurch B. PMID: 37499088; PMCID: PMC10374192.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. Evaluation of clinical performance and safety for the rechargeable InterStim Micro device in overactive bladder subjects: 6-month results from the global postmarket ELITE study. Neurourol Urodyn. 2023 04; 42(4):761-769. Goudelocke C, Xavier K, Pecha B, Burgess K, Perrouin-Verbe MA, Krlin R, Michaels J, Shah S, Peyronnet B, Zaslau S, Champs M, Papi B, Bittner K, Elterman D, Nitti V. PMID: 36917003.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Cost-effectiveness of overactive bladder treatments from a US commercial and payer perspective. J Comp Eff Res. 2023 02; 12(2):e220089. Murray B, Miles-Thomas J, Park AJ, Nguyen VB, Tung A, Gillard P, Lalla A, Nitti VW, Chermansky CJ. PMID: 36655745; PMCID: PMC10288955.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Faculty and applicant perceptions of virtual interviews on subspecialty fellowship match in obstetrics and gynecology. Med Educ Online. 2022 Dec; 27(1):2068993. Armstrong A, Kroener L, Cohen JG, Han CS, Nitti VW, Rible R, Brennan K. PMID: 35473575; PMCID: PMC9067945.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    8. Overactive Bladder Patients With and Without Urgency Incontinence: A Spectrum of One Condition or Different Phenotypes? Urogynecology (Phila). 2023 01 01; 29(1):33-40. Torosis M, Jackson N, Nitti V, Ackerman AL. PMID: 36548103; PMCID: PMC9859670.
      View in: PubMed   Mentions: 1  Translation:Humans
    9. Sensation of incomplete bladder emptying in women: Lack of correlation to an elevated post-void residual. Neurourol Urodyn. 2022 01; 41(1):490-497. Van Kuiken M, Volkin D, Zaila Ardines K, Lin FC, Fullerton M, Kwan L, Nitti VW. PMID: 34913516.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. The Effect of Symptomatic Stress Urinary Incontinence on Catheterization Rates After Intradetrusor OnabotulinumtoxinA Injections. Female Pelvic Med Reconstr Surg. 2021 11 01; 27(11):676-680. Brandon C, Pape DM, Oh C, Kreines FM, Thakker SS, Rosenblum N, Nitti VW, Brucker BM, Glass D. PMID: 34009831.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Dorsal Onlay Oral Mucosa Graft Urethroplasty for Female Urethral Stricture. Urology. 2021 12; 158:215-221. Richard C, Peyronnet B, Drain A, Rosenblum N, Hascoet J, Sussman RD, Freton L, Zhao LC, Nitti VW, Brucker BM. PMID: 34537197.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Impact of Fellowship-Trained Andrology and Sexual Medicine Specialists on Performance on the Annual American Urological Association In-Service Examination. Urology. 2021 11; 157:51-56. El-Arabi AM, Alam SM, Dai J, Thompson J, Baden M, Siculietano J, Kerley P, Englert S, Nitti VW, Hussman DA, Thrasher JB, Brannigan RE, Sandlow JI, Nangia AK. PMID: 34186132.
      View in: PubMed   Mentions: 1     Fields:    
    13. Estimation of Urinary Frequency: Does Question Phrasing Matter? Urology. 2021 10; 156:90-95. Sussman RD, Escobar C, Jericevic D, Oh C, Arslan A, Palmerola R, Pape DM, Smilen SW, Nitti VW, Rosenblum N, Brucker BM. PMID: 33901531.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Diagnosis and management of overactive bladder: A review. J Obstet Gynaecol Res. 2021 May; 47(5):1654-1665. Nitti VW, Patel A, Karram M. PMID: 33592680.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    15. Persistence in Percutaneous Tibial Nerve Stimulation Treatment for Overactive Bladder Syndrome is Best Predicted by Patient Global Impression of Improvement Rather Than Symptom-Specific Improvement. Urology. 2021 02; 148:93-99. Brandon C, Oh C, Brucker BM, Rosenblum N, Ferrante KL, Smilen SW, Nitti VW, Pape DM. PMID: 33358753.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Gel-Infused Translabial Ultrasound in the Evaluation of Female Urethral Stricture. Female Pelvic Med Reconstr Surg. 2020 12 01; 26(12):737-741. Sussman RD, Kozirovsky M, Telegrafi S, Peyronnet B, Palmerola R, Smilen S, Pape DM, Rosenblum N, Nitti VW, Brucker BM. PMID: 30664026.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Rectus Fascia Versus Fascia Lata for Autologous Fascial Pubovaginal Sling: A Single-Center Comparison of Perioperative and Functional Outcomes. Female Pelvic Med Reconstr Surg. 2020 08; 26(8):493-497. Peng M, Sussman RD, Escobar C, Palmerola R, Pape DM, Smilen SS, Rosenblum N, Brucker BM, Peyronnet B, Nitti VW. PMID: 31343622.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Evaluating the safety and potential activity of URO-902 (hMaxi-K) gene transfer by intravesical instillation or direct injection into the bladder wall in female participants with idiopathic (non-neurogenic) overactive bladder syndrome and detrusor overactivity from two double-blind, imbalanced, placebo-controlled randomized phase 1 trials. Neurourol Urodyn. 2020 02; 39(2):744-753. Rovner E, Chai TC, Jacobs S, Christ G, Andersson KE, Efros M, Nitti V, Davies K, McCullough AR, Melman A. PMID: 31945197; PMCID: PMC7028015.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    19. Radiation exposure during videourodynamic testing: Is dose reduction possible using a standardized protocol? Neurourol Urodyn. 2020 02; 39(2):715-720. Hoffman D, Sussman RD, Pape DM, Smilen SW, Rosenblum N, Nitti VW, Brucker BM. PMID: 31846117.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    20. Current Role of Urethrolysis and Partial Excision in Patients Seeking Revision of Anti-Incontinence Sling. Female Pelvic Med Reconstr Surg. 2019 Nov/Dec; 25(6):409-414. Drain A, Enemchukwu E, Shah N, Syan R, Rosenblum N, Nitti VW, Brucker BM. PMID: 29787462.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    21. Urodynamic Mechanisms Underlying Overactive Bladder Symptoms in Patients With Parkinson Disease. Int Neurourol J. 2019 Sep; 23(3):211-218. Vurture G, Peyronnet B, Palma JA, Sussman RD, Malacarne DR, Feigin A, Palmerola R, Rosenblum N, Frucht S, Kaufmann H, Nitti VW, Brucker BM. PMID: 31607100; PMCID: PMC6790817.
      View in: PubMed   Mentions: 3  
    22. Impact of preoperative urodynamics on women undergoing pelvic organ prolapse surgery. Int Urogynecol J. 2020 08; 31(8):1663-1668. Glass D, Lin FC, Khan AA, Van Kuiken M, Drain A, Siev M, Peyronett B, Rosenblum N, Brucker BM, Nitti VW. PMID: 31456030.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. Incontinence after Prostate Treatment: AUA/SUFU Guideline. J Urol. 2019 08; 202(2):369-378. Sandhu JS, Breyer B, Comiter C, Eastham JA, Gomez C, Kirages DJ, Kittle C, Lucioni A, Nitti VW, Stoffel JT, Westney OL, Murad MH, McCammon K. PMID: 31059663.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansPHPublic Health
    24. Trends in Stress Urinary Incontinence Surgery at a Tertiary Center: Midurethral Sling Use Following the AUGS/SUFU Position Statement. Urology. 2019 09; 131:71-76. Palmerola R, Peyronnet B, Rebolos M, Khan A, Sussman RD, Escobar C, Smith S, Rosenblum N, Nitti VW. PMID: 31229514.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    25. A Prospective Study to Evaluate Efficacy Using the Nuro Percutaneous Tibial Neuromodulation System in Drug-Naïve Patients With Overactive Bladder Syndrome. Urology. 2019 Sep; 131:77-82. Kobashi K, Nitti V, Margolis E, Sand P, Siegel S, Khandwala S, Newman D, MacDiarmid SA, Kan F, Michaud E. PMID: 31199966.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    26. Nocturia in female patients: Current clinical features, treatment patterns and outcomes at a tertiary referral centre. Arab J Urol. 2019 Mar; 17(1):82-86. Drangsholt S, Peyronnet B, Arcila-Ruiz M, Sussman RD, Palmerola R, Pape DR, Rosenblum N, Nitti VW, Brucker BM. PMID: 31258948; PMCID: PMC6583713.
      View in: PubMed   Mentions: 3  
    27. Exploring stress urinary incontinence outcomes after sling excision for perforation or exposure. Low Urin Tract Symptoms. 2019 Sep; 11(4):206-210. Syan R, Peyronnet B, Drain A, Enemchukwu E, Malacarne DR, Rosenblum N, Nitti VW, Brucker BM. PMID: 30900401.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    28. The development of the ICIQ-UAB: A patient reported outcome measure for underactive bladder. Neurourol Urodyn. 2019 03; 38(3):996-1004. Uren AD, Cotterill N, Harding C, Hillary C, Chapple C, Lasch K, Stroupe A, Deshpande C, Delbecque L, Van Koeveringe G, Oelke M, Belal M, Bosch R, Blok B, Nitti V, Gotoh M, Takei M, Crawford B, Klaver M, Bongaerts D, Hakimi Z, Kos T, Abrams P. PMID: 30801826.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Effect of Radiation on Male Stress Urinary Incontinence and the Role of Urodynamic Assessment. Urology. 2019 Mar; 125:58-63. Hoffman D, Vijay V, Peng M, Sussman RD, Rosenblum N, Brucker BM, Peyronnet B, Nitti VW. PMID: 30508511.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. AMS-800 Artificial urinary sphincter in female patients with stress urinary incontinence: A systematic review. Neurourol Urodyn. 2019 08; 38 Suppl 4:S28-S41. Peyronnet B, O'Connor E, Khavari R, Capon G, Manunta A, Allue M, Hascoet J, Nitti VW, Gamé X, Gilleran J, Castro-Sader L, Cornu JN, Waltregny D, Ahyai S, Chung E, Elliott DS, Fournier G, Brucker BM. PMID: 30298943.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    31. Diagnosis and management of nocturia in current clinical practice: who are nocturia patients, and how do we treat them? World J Urol. 2019 Jul; 37(7):1389-1394. Drangsholt S, Ruiz MJA, Peyronnet B, Rosenblum N, Nitti V, Brucker B. PMID: 30288596.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    32. Terminology report from the International Continence Society (ICS) Working Group on Underactive Bladder (UAB). Neurourol Urodyn. 2018 11; 37(8):2928-2931. Chapple CR, Osman NI, Birder L, Dmochowski R, Drake MJ, van Koeveringe G, Nitti VW, Oelke M, Smith PP, Yamaguchi O, Wein A, Abrams P. PMID: 30203560.
      View in: PubMed   Mentions: 18     Fields:    
    33. Mirabegron in patients with Parkinson disease and overactive bladder symptoms: A retrospective cohort. Parkinsonism Relat Disord. 2018 12; 57:22-26. Peyronnet B, Vurture G, Palma JA, Malacarne DR, Feigin A, Sussman RD, Biagioni MC, Palmerola R, Gilbert R, Rosenblum N, Frucht S, Kaufmann H, Nitti VW, Brucker BM. PMID: 30037689.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    34. Outcomes of intradetrusor onabotulinum toxin A injection in patients with Parkinson's disease. Neurourol Urodyn. 2018 11; 37(8):2669-2677. Vurture G, Peyronnet B, Feigin A, Biagioni MC, Gilbert R, Rosenblum N, Frucht S, Di Rocco A, Nitti VW, Brucker BM. PMID: 29767449.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    35. The history of the Society of Urodynamics, Female Pelvic Medicine, and Urogenital Reconstruction. Neurourol Urodyn. 2018 08; 37(6):2015-2025. Weissbart SJ, Zimmern PE, Nitti VW, Lemack GE, Kobashi KC, Vasavada SP, Wein AJ. PMID: 29575219.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. Long-term efficacy: The Achille's heel of the male sling? Prog Urol. 2018 03; 28(4):191-192. Peyronnet B, Nitti VW, Brucker BM. PMID: 29402704.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    37. Botulinum Toxin Use in Neurourology. Rev Urol. 2018; 20(2):84-93. Peyronnet B, Gamé X, Vurture G, Nitti VW, Brucker BM. PMID: 30288145; PMCID: PMC6168325.
      View in: PubMed   Mentions: 3  
    38. Surgical Treatment of Male Postprostatectomy Incontinence: Current Concepts. Eur Urol Focus. 2017 10; 3(4-5):364-376. Kretschmer A, Nitti V. PMID: 29174616.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    39. Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis. BJU Int. 2017 11; 120(5):611-622. Drake MJ, Nitti VW, Ginsberg DA, Brucker BM, Hepp Z, McCool R, Glanville JM, Fleetwood K, James D, Chapple CR. PMID: 28670786.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    40. Long-Term Treatment with OnabotulinumtoxinA Results in Consistent, Durable Improvements in Health Related Quality of Life in Patients with Overactive Bladder. J Urol. 2017 10; 198(4):897-904. Ginsberg DA, Drake MJ, Kaufmann A, Radomski S, Gousse AE, Chermansky CJ, Magyar A, Nicandro JP, Nitti VW, 191622-096 Investigators. PMID: 28536084.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    41. Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies. Ther Adv Urol. 2017 Dec; 9(6):137-154. Tubaro A, Batista JE, Nitti VW, Herschorn S, Chapple CR, Blauwet MB, Siddiqui E, Huang M, Oelke M. PMID: 28588652; PMCID: PMC5444577.
      View in: PubMed   Mentions: 20  
    42. Midurethral sling erosion: NYU Case of the Month, August 2017. Rev Urol. 2017; 19(3):185-186. Nitti VW. PMID: 29302242; PMCID: PMC5737346.
      View in: PubMed   Mentions:
    43. Risk Factors for Urinary Tract Infection following Mid Urethral Sling Surgery. J Urol. 2017 05; 197(5):1268-1273. Vigil HR, Mallick R, Nitti VW, Lavallée LT, Breau RH, Hickling DR. PMID: 28034608.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    44. OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial. J Urol. 2017 02; 197(2S):S216-S223. Nitti VW, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C, Yan X, Haag-Molkenteller C, EMBARK Study Group. PMID: 28012773.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    45. Radiation Exposure During Videourodynamics: Establishing Risk Factors. Low Urin Tract Symptoms. 2018 May; 10(2):181-185. Brucker BM, Campeau L, Fong E, Kalra S, Rosenblum N, Nitti VW. PMID: 27990783.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    46. Use of Concomitant Stress Incontinence Surgery at Time of Pelvic Organ Prolapse Surgery Since Release of the 2011 Notification on Serious Complications Associated with Transvaginal Mesh. J Urol. 2017 04; 197(4):1092-1098. Drain A, Khan A, Ohmann EL, Brucker BM, Smilen S, Rosenblum N, Nitti VW. PMID: 27866958.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    47. Post-Sling Urinary Retention in Women. Curr Urol Rep. 2016 Nov; 17(11):83. Malacarne DR, Nitti VW. PMID: 27678391.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    48. Barriers experienced by patients with multiple sclerosis in seeking care for lower urinary tract symptoms. Neurourol Urodyn. 2017 Apr; 36(4):1208-1213. Brucker BM, Nitti VW, Kalra S, Herbert J, Sadiq A, Utomo P, Aponte MM. PMID: 27548624.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    49. Stress urinary incontinence surgery trends in academic female pelvic medicine and reconstructive surgery urology practice in the setting of the food and drug administration public health notifications. Neurourol Urodyn. 2017 04; 36(4):1155-1160. Rac G, Younger A, Clemens JQ, Kobashi K, Khan A, Nitti V, Jacobs I, Lemack GE, Brown ET, Dmochowski R, MacLachlan L, Mourtzinos A, Ginsberg D, Koski M, Rames R, Rovner ES. PMID: 27460448.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansPHPublic Health
    50. Long-Term Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Who Completed 4 Years of Treatment. J Urol. 2016 Sep; 196(3):801-8. Rovner E, Kohan A, Chartier-Kastler E, Jünemann KP, Del Popolo G, Herschorn S, Joshi M, Magyar A, Nitti V. PMID: 27091236.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    51. Clinical Case Discussion: Failure of a Midurethral Sling Procedure for Stress Urinary Incontinence in a Female Patient. Eur Urol Focus. 2016 Aug; 2(3):335-336. Drain A, Nitti VW. PMID: 28723384.
      View in: PubMed   Mentions:    Fields:    
    52. Female Bladder Outlet Obstruction. Curr Urol Rep. 2016 Apr; 17(4):31. Hoffman DS, Nitti VW. PMID: 26902625.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    53. Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study. J Urol. 2016 Sep; 196(3):791-800. Nitti VW, Ginsberg D, Sievert KD, Sussman D, Radomski S, Sand P, De Ridder D, Jenkins B, Magyar A, Chapple C, 191622-096 Investigators. PMID: 27038769.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    54. Oral pharmacotherapy for overactive bladder in older patients: mirabegron as a potential alternative to antimuscarinics. Curr Med Res Opin. 2016; 32(4):621-38. Wagg A, Nitti VW, Kelleher C, Castro-Diaz D, Siddiqui E, Berner T. PMID: 26828974.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    55. Pelvic Organ Prolapse Surgery in Academic Female Pelvic Medicine and Reconstructive Surgery Urology Practice in the Setting of the Food and Drug Administration Public Health Notifications. Urology. 2016 05; 91:46-51. Younger A, Rac G, Clemens JQ, Kobashi K, Khan A, Nitti V, Jacobs I, Lemack GE, Brown ET, Dmochowski R, Maclachlan L, Mourtzinos A, Ginsberg D, Koski M, Rames R, Rovner E. PMID: 26845051.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    56. Durable improvements in urinary incontinence and positive treatment response in patients with idiopathic overactive bladder syndrome following long-term onabotulinumtoxinA treatment: Final results of 3.5-year study. Prog Urol. 2015 Nov; 25(13):739. Chartier-Kastler E, Nitti V, De Ridder D, Sussman D, Sand P, Sievert K, Chapple C, Charmaine J, Magyar A, Radomski S. PMID: 26544243.
      View in: PubMed   Mentions: 2     Fields:    
    57. Cardiovascular Safety of β3-adrenoceptor Agonists for the Treatment of Patients with Overactive Bladder Syndrome. Eur Urol. 2016 Feb; 69(2):311-23. Rosa GM, Ferrero S, Nitti VW, Wagg A, Saleem T, Chapple CR. PMID: 26422675.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    58. The underactive bladder: a new clinical concept? Eur Urol. 2015 Sep; 68(3):351-3. Chapple CR, Osman NI, Birder L, van Koeveringe GA, Oelke M, Nitti VW, Drake MJ, Yamaguchi O, Abrams P, Smith PP. PMID: 25770481.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    59. Evaluating patients' symptoms of overactive bladder by questionnaire: the role of urgency in urinary frequency. Urology. 2014 Nov; 84(5):1039-43. Mitchell SA, Brucker BM, Kaefer D, Aponte M, Rosenblum N, Kelly C, Hickling D, Nitti VW. PMID: 25443897.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    60. Efficacy of the β3-adrenoceptor agonist mirabegron for the treatment of overactive bladder by severity of incontinence at baseline: a post hoc analysis of pooled data from three randomised phase 3 trials. Eur Urol. 2015 Jan; 67(1):11-14. Chapple C, Khullar V, Nitti VW, Frankel J, Herschorn S, Kaper M, Blauwet MB, Siddiqui E. PMID: 25092537.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    61. Urodynamics. Urol Clin North Am. 2014 Aug; 41(3):xiii. Brucker BM, Nitti VW. PMID: 25063604.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    62. Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB). Neurourol Urodyn. 2014 Jul; 33 Suppl 3:S26-31. Cruz F, Nitti V. PMID: 25042140.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    63. The virtue sling--a new quadratic sling for postprostatectomy incontinence--results of a multinational clinical trial. Urology. 2014 Aug; 84(2):433-8. Comiter CV, Rhee EY, Tu LM, Herschorn S, Nitti VW. PMID: 24972946.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    64. Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder. Int Urogynecol J. 2014 Dec; 25(12):1655-63. Cardozo L, Staskin D, Currie B, Wiklund I, Globe D, Signori M, Dmochowski R, MacDiarmid S, Nitti VW, Noblett K. PMID: 24859795; PMCID: PMC4234889.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    65. OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder. Int J Clin Pract. 2014 Oct; 68(10):1246-56. Sievert KD, Chapple C, Herschorn S, Joshi M, Zhou J, Nardo C, Nitti VW. PMID: 24754838; PMCID: PMC4282287.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    66. Safety and tolerability of the β3 -adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12-week randomised Phase III trials and of a 1-year randomised Phase III trial. Int J Clin Pract. 2014 Aug; 68(8):972-85. Nitti VW, Chapple CR, Walters C, Blauwet MB, Herschorn S, Milsom I, Auerbach S, Radziszewski P. PMID: 24703195.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    67. Correlation of patient perception of pad use with objective degree of incontinence measured by pad test in men with post-prostatectomy incontinence: the SUFU Pad Test Study. J Urol. 2014 Sep; 192(3):836-42. Nitti VW, Mourtzinos A, Brucker BM, SUFU Pad Test Study Group. PMID: 24650425.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    68. The efficacy and tolerability of the β3-adrenoceptor agonist mirabegron for the treatment of symptoms of overactive bladder in older patients. Age Ageing. 2014 Sep; 43(5):666-75. Wagg A, Cardozo L, Nitti VW, Castro-Diaz D, Auerbach S, Blauwet MB, Siddiqui E. PMID: 24610862.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    69. Onset of action of the β3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder. World J Urol. 2014 Dec; 32(6):1565-72. Chapple CR, Nitti VW, Khullar V, Wyndaele JJ, Herschorn S, van Kerrebroeck P, Blauwet MB, Siddiqui E. PMID: 24458878; PMCID: PMC4236626.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    70. Neurological status predicts response to alpha-blockers in men with voiding dysfunction and Parkinson's disease. Clinics (Sao Paulo). 2014; 69(12):817-22. Gomes CM, Sammour ZM, Bessa Junior Jd, Barbosa ER, Lopes RI, Sallem FS, Trigo-Rocha FE, Bruschini H, Nitti VW, Srougi M. PMID: 25627993; PMCID: PMC4286669.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    71. Artificial urinary sphincter revision: the role of ultrasound. Urology. 2013 Dec; 82(6):1424-8. Brucker BM, Demirtas A, Fong E, Kelly C, Nitti VW. PMID: 24295256.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    72. Reply: To PMID 24295256. Urology. 2013 Dec; 82(6):1429. Brucker BM, Nitti VW. PMID: 24295258.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    73. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol. 2014 Feb; 65(2):389-98. Osman NI, Chapple CR, Abrams P, Dmochowski R, Haab F, Nitti V, Koelbl H, van Kerrebroeck P, Wein AJ. PMID: 24184024.
      View in: PubMed   Mentions: 99     Fields:    Translation:Humans
    74. Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn. 2014 Jan; 33(1):17-30. Chapple CR, Cardozo L, Nitti VW, Siddiqui E, Michel MC. PMID: 24127366.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansAnimals
    75. Uterine sparing robotic-assisted laparoscopic sacrohysteropexy for pelvic organ prolapse: safety and feasibility. J Endourol. 2013 Sep; 27(9):1131-6. Lee T, Rosenblum N, Nitti V, Brucker BM. PMID: 23713544.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    76. Evidence available on the use of the selective β3-adrenoceptor agonist mirabegron for the treatment of overactive bladder. Actas Urol Esp. 2013 Nov-Dec; 37(10):640-51. Angulo JC, Khullar V, Nitti VW, Siddiqui E. PMID: 23850394.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    77. Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool. BMC Neurol. 2013 Jul 09; 13:78. Bates D, Burks J, Globe D, Signori M, Hudgens S, Denys P, Macdiarmid S, Nitti V, Odderson I, Ross AP, Chancellor M. PMID: 23837535; PMCID: PMC3728236.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    78. Urodynamics and safety of the β₃-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction. J Urol. 2013 Oct; 190(4):1320-7. Nitti VW, Rosenberg S, Mitcheson DH, He W, Fakhoury A, Martin NE. PMID: 23727415.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    79. Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies. Int J Clin Pract. 2013 Jul; 67(7):619-32. Nitti VW, Khullar V, van Kerrebroeck P, Herschorn S, Cambronero J, Angulo JC, Blauwet MB, Dorrepaal C, Siddiqui E, Martin NE. PMID: 23692526; PMCID: PMC3752932.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    80. Urodynamics for clinically suspected obstruction after anti-incontinence surgery in women. J Urol. 2013 Aug; 190(2):598-602. Aponte MM, Shah SR, Hickling D, Brucker BM, Rosenblum N, Nitti VW. PMID: 23567748.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    81. Selective β₃-adrenoceptor agonists for the treatment of overactive bladder. J Urol. 2013 Oct; 190(4):1173-80. Andersson KE, Martin N, Nitti V. PMID: 23458471.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    82. Different surgical approaches for stress urinary incontinence in women. Minerva Ginecol. 2013 Feb; 65(1):21-8. Mischinger J, Amend B, Reisenauer C, Bedke J, Naumann G, Germann M, Kruck S, Arenas Desilva LF, Wallwiener H, Koelbl H, Nitti V, Sievert KD. PMID: 23412017.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    83. Comparison of urodynamic findings in women with anatomical versus functional bladder outlet obstruction. Female Pelvic Med Reconstr Surg. 2013 Jan-Feb; 19(1):46-50. Brucker BM, Shah S, Mitchell S, Fong E, Nitti MD, Kelly CE, Rosenblum N, Nitti VW. PMID: 23321659.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    84. Management of recurrent urinary tract infections in healthy adult women. Rev Urol. 2013; 15(2):41-8. Hickling DR, Nitti VW. PMID: 24082842; PMCID: PMC3784967.
      View in: PubMed   Mentions: 18  
    85. Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patients. Int J MS Care. 2013; 15(4):182-92. Burks J, Chancellor M, Bates D, Denys P, Macdiarmid S, Nitti V, Globe D, Signori M, Hudgens S, Odderson I, Panicker J, Ross AP. PMID: 24453782; PMCID: PMC3883018.
      View in: PubMed   Mentions: 21  
    86. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol. 2013 Jun; 189(6):2186-93. Nitti VW, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C, Yan X, Haag-Molkenteller C, EMBARK Study Group. PMID: 23246476.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansCTClinical Trials
    87. Urodynamic studies in adults: AUA/SUFU guideline. J Urol. 2012 Dec; 188(6 Suppl):2464-72. Winters JC, Dmochowski RR, Goldman HB, Herndon CD, Kobashi KC, Kraus SR, Lemack GE, Nitti VW, Rovner ES, Wein AJ, American Urological Association, Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction. PMID: 23098783.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    88. Results of a randomized phase III trial of mirabegron in patients with overactive bladder. J Urol. 2013 Apr; 189(4):1388-95. Nitti VW, Auerbach S, Martin N, Calhoun A, Lee M, Herschorn S. PMID: 23079373.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCTClinical Trials
    89. Appropriate workup for lower urinary tract symptoms in men. Can Urol Assoc J. 2012 Oct; 6(5 Suppl 2):S141-2. Nitti VW. PMID: 23092780; PMCID: PMC3481950.
      View in: PubMed   Mentions:
    90. Complications of midurethral slings and their management. Can Urol Assoc J. 2012 Oct; 6(5 Suppl 2):S120-2. Nitti VW. PMID: 23092771; PMCID: PMC3481947.
      View in: PubMed   Mentions: 12  
    91. Evaluation and management of outlet obstruction in women without anatomical abnormalities on physical exam or cystoscopy. Curr Urol Rep. 2012 Oct; 13(5):356-62. Hickling D, Aponte M, Nitti V. PMID: 22872500.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    92. Urodynamic findings in women with insensible incontinence. Int J Urol. 2013 Apr; 20(4):429-33. Brucker BM, Fong E, Kaefer D, Shah S, Rosenblum N, Nitti VW. PMID: 22970923.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    93. Midurethral slings for all stress incontinence: a urology perspective. Urol Clin North Am. 2012 Aug; 39(3):299-310. Lee E, Nitti VW, Brucker BM. PMID: 22877712.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    94. Urodynamic differences between dysfunctional voiding and primary bladder neck obstruction in women. Urology. 2012 Jul; 80(1):55-60. Brucker BM, Fong E, Shah S, Kelly C, Rosenblum N, Nitti VW. PMID: 22748864.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    95. Long-term continence after surgery--what can we tell patients? J Urol. 2012 Apr; 187(4):1157-8. Nitti VW. PMID: 22335877.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    96. Can noninvasive evaluation of benign prostatic obstruction be optimized? Curr Opin Urol. 2012 Jan; 22(1):1-6. Løvvik A, Yaqub S, Oustad H, Sand TE, Nitti VW. PMID: 22080874.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    97. A new quadratic sling for male stress incontinence: retrograde leak point pressure as a measure of urethral resistance. J Urol. 2012 Feb; 187(2):563-8. Comiter CV, Nitti V, Elliot C, Rhee E. PMID: 22177174.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    98. Treatment of post-prostatectomy incontinence with male slings in patients with impaired detrusor contractility on urodynamics and/or who perform Valsalva voiding. J Urol. 2011 Oct; 186(4):1370-5. Han JS, Brucker BM, Demirtas A, Fong E, Nitti VW. PMID: 21855941.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    99. Clinical testing for overactive bladder. Can Urol Assoc J. 2011 Oct; 5(5 Suppl 2):S137-8. Nitti V. PMID: 21989526; PMCID: PMC3193395.
      View in: PubMed   Mentions: 1  
    100. Surgical management of Skene's gland abscess/infection: a contemporary series. Int Urogynecol J. 2012 Feb; 23(2):159-64. Shah SR, Biggs GY, Rosenblum N, Nitti VW. PMID: 21732101.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    101. Contemporary management of postprostatectomy incontinence. Eur Urol. 2011 Jun; 59(6):985-96. Bauer RM, Gozzi C, Hübner W, Nitti VW, Novara G, Peterson A, Sandhu JS, Stief CG. PMID: 21458914.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    102. Female urethral reconstruction. Urol Clin North Am. 2011 Feb; 38(1):55-64, vi. Rosenblum N, Nitti VW. PMID: 21353080.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    103. Editorial comment. Urology. 2011 Feb; 77(2):325; author reply 325. Nitti VW. PMID: 21295250.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    104. Editorial comment. Urology. 2011 Feb; 77(2):479; author reply 480. Nitti VW. PMID: 21295255.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    105. Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. J Urol. 2010 Dec; 184(6):2416-22. Dmochowski R, Chapple C, Nitti VW, Chancellor M, Everaert K, Thompson C, Daniell G, Zhou J, Haag-Molkenteller C. PMID: 20952013.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansCTClinical Trials
    106. Urinary incontinence. Prim Care. 2010 Sep; 37(3):599-612, ix. Fong E, Nitti VW. PMID: 20705201.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    107. Review article: Mid-urethral synthetic slings for female stress urinary incontinence. BJU Int. 2010 Sep; 106(5):596-608. Fong ED, Nitti VW. PMID: 21050350.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    108. Can we predict which patient will fail drug treatment for overactive bladder? A think tank discussion. Neurourol Urodyn. 2010 Apr; 29(4):652-7. Nitti VW, Kopp Z, Lin AT, Moore KH, Oefelein M, Mills IW. PMID: 20432330.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    109. Efficacy of fesoterodine over 24 hours in subjects with overactive bladder. Curr Med Res Opin. 2010 Apr; 26(4):813-8. Staskin D, Michel MC, Nitti V, Morrow JD, Wang J, Guan Z. PMID: 20121659.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    110. Outcomes of patients lost to followup after mid urethral synthetic slings--successes or failures? J Urol. 2010 Apr; 183(4):1455-8. Ballert KN, Rose AE, Biggs GY, Rosenblum N, Nitti VW. PMID: 20171698.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    111. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010; 29(1):213-40. Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C, Cottenden A, Davila W, de Ridder D, Dmochowski R, Drake M, Dubeau C, Fry C, Hanno P, Smith JH, Herschorn S, Hosker G, Kelleher C, Koelbl H, Khoury S, Madoff R, Milsom I, Moore K, Newman D, Nitti V, Norton C, Nygaard I, Payne C, Smith A, Staskin D, Tekgul S, Thuroff J, Tubaro A, Vodusek D, Wein A, Wyndaele JJ, Members of Committees, Fourth International Consultation on Incontinence. PMID: 20025020.
      View in: PubMed   Mentions: 291     Fields:    Translation:Humans
    112. Association between detrusor overactivity and postoperative outcomes in patients undergoing male bone anchored perineal sling. J Urol. 2010 Feb; 183(2):641-5. Ballert KN, Nitti VW. PMID: 20018325.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    113. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity. BJU Int. 2010 May; 105(9):1268-75. Nitti VW, Rovner ES, Bavendam T. PMID: 19889062.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    114. Fistulization between ectopic ureteral stump and uterus following nephroureterectomy: case report. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Dec; 20(12):1505-7. Mufarrij PW, Ballert KN, Nitti VW. PMID: 19444370.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    115. Efficacy and tolerability of fesoterodine in women with overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Jul; 20(7):827-35. Sand PK, Morrow JD, Bavendam T, Creanga DL, Nitti VW. PMID: 19495545.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    116. Artificial urinary sphincter versus male sling for post-prostatectomy incontinence--what do patients choose? J Urol. 2009 Mar; 181(3):1231-5. Kumar A, Litt ER, Ballert KN, Nitti VW. PMID: 19152937.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    117. Defining efficacy in the treatment of overactive bladder syndrome. Rev Urol. 2009; 11(4):196-202. Shah S, Nitti VW. PMID: 20111632; PMCID: PMC2809987.
      View in: PubMed   Mentions: 8  
    118. Patient-reported outcomes for tension-free vaginal tape-obturator in women treated with a previous anti-incontinence procedure. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Mar; 20(3):331-5. Biggs GY, Ballert KN, Rosenblum N, Nitti V. PMID: 19107314.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    119. Managing the urethra at transvaginal pelvic organ prolapse repair: a urodynamic approach. J Urol. 2009 Feb; 181(2):679-84. Ballert KN, Biggs GY, Isenalumhe A, Rosenblum N, Nitti VW. PMID: 19091337.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    120. Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study. Mayo Clin Proc. 2008 Sep; 83(9):1002-10. MacDiarmid SA, Peters KM, Chen A, Armstrong RB, Orman C, Aquilina JW, Nitti VW. PMID: 18775200.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    121. Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder. Urology. 2008 Oct; 72(4):803-7. Colman S, Chapple C, Nitti V, Haag-Molkenteller C, Hastedt C, Massow U. PMID: 18722655.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    122. Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder. Urology. 2008 Sep; 72(3):488-93. Rovner ES, Rackley R, Nitti VW, Wang JT, Guan Z, 037 Study Group. PMID: 18639327.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    123. Fesoterodine dose response in subjects with overactive bladder syndrome. Urology. 2008 May; 71(5):839-43. Khullar V, Rovner ES, Dmochowski R, Nitti V, Wang J, Guan Z. PMID: 18342923.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    124. Urodynamics, Incontinence, and Neurourology: Highlights from the Society for Urodynamics and Female Urology Annual Winter Meeting, February 28-March 2, 2008, Miami, FL. Rev Urol. 2008; 10(3):229-31. Nitti VW. PMID: 18836560; PMCID: PMC2556490.
      View in: PubMed   Mentions:
    125. Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome. J Urol. 2007 Dec; 178(6):2488-94. Nitti VW, Dmochowski R, Sand PK, Forst HT, Haag-Molkenteller C, Massow U, Wang J, Brodsky M, Bavendam T. PMID: 17937959.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    126. Effect of tension-free vaginal tape and TVT-obturator on lower urinary tract symptoms other than stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Mar; 19(3):335-40. Ballert KN, Kanofsky JA, Nitti VW. PMID: 17874026.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    127. Primary bladder neck obstruction in men, women, and children. Curr Urol Rep. 2007 Sep; 8(5):379-84. Padmanabhan P, Nitti VW. PMID: 17880837.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    128. Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence. Urology. 2007 May; 69(5):876-80. Mayer RD, Dmochowski RR, Appell RA, Sand PK, Klimberg IW, Jacoby K, Graham CW, Snyder JA, Nitti VW, Winters JC. PMID: 17482925.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimals
    129. The male perineal sling: assessment and prediction of outcome. J Urol. 2007 Apr; 177(4):1414-8. Fischer MC, Huckabay C, Nitti VW. PMID: 17382743.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    130. Comparison between reduction in 24-hour pad weight, International Consultation on Incontinence-Short Form (ICIQ-SF) score, International Prostate Symptom Score (IPSS), and Post-Operative Patient Global Impression of Improvement (PGI-I) score in patient evaluation after male perineal sling. Neurourol Urodyn. 2007; 26(1):8-13. Twiss CO, Fischer MC, Nitti VW. PMID: 17016797.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    131. Comparison of diagnostic criteria for female bladder outlet obstruction. J Urol. 2006 Nov; 176(5):2093-7. Akikwala TV, Fleischman N, Nitti VW. PMID: 17070266.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    132. Tolterodine for treatment of overactive bladder. Urol Clin North Am. 2006 Nov; 33(4):447-53, viii. Kanofsky JA, Nitti VW. PMID: 17011380.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    133. Female stress urinary incontinence: how do patient and physician perspectives correlate in assessment of outcomes? Curr Opin Urol. 2006 Jul; 16(4):212-8. Padmanabhan P, Nitti VW. PMID: 16770116.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    134. Efficacy and tolerability of tolterodine extended-release in continent patients with overactive bladder and nocturia. BJU Int. 2006 Jun; 97(6):1262-6. Nitti VW, Dmochowski R, Appell RA, Wang JT, Bavendam T, Guan Z, 037 Study Group. PMID: 16686723.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    135. Improving the global management of the neurogenic bladder patient: part II. Future treatment strategies. Curr Med Res Opin. 2006 May; 22(5):851-60. Denys P, Corcos J, Everaert K, Chartier-Kastler E, Fowler C, Kalsi V, Nitti V, Schulte-Baukloh H, Schurch B. PMID: 16709307.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    136. Transdermal delivery of drugs for urologic applications: basic principles and applications. Urology. 2006 Apr; 67(4):657-64. Nitti VW, Sanders S, Staskin DR, Dmochowski RR, Sand PK, MacDiarmid S, Maibach HI. PMID: 16618554.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    137. Improving the global management of the neurogenic bladder patient: part I. The complexity of patients. Curr Med Res Opin. 2006 Feb; 22(2):359-65. Denys P, Corcos J, Everaert K, Chartier-Kastler E, Fowler C, Kalsi V, Nitti V, Schulte-Baukloh H, Schurch B. PMID: 16466608.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    138. Botulinum toxin for the treatment of idiopathic and neurogenic overactive bladder: state of the art. Rev Urol. 2006; 8(4):198-208. Nitti VW. PMID: 17192799; PMCID: PMC1751031.
      View in: PubMed   Mentions: 10  
    139. Transdermal oxybutynin in the treatment of adults with overactive bladder: combined results of two randomized clinical trials. World J Urol. 2005 Sep; 23(4):263-70. Dmochowski RR, Nitti V, Staskin D, Luber K, Appell R, Davila GW. PMID: 16151816.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    140. Bladder-health diaries: an assessment of 3-day vs 7-day entries. BJU Int. 2005 Nov; 96(7):1049-54. Dmochowski RR, Sanders SW, Appell RA, Nitti VW, Davila GW. PMID: 16225527.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    141. Surgical treatment of stress urinary incontinence in women: is "clinical effectiveness" a valid concept? Curr Urol Rep. 2005 Sep; 6(5):319-21. Nitti VW. PMID: 16120230.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    142. Diagnosis and treatment of primary bladder neck obstruction in men. Curr Urol Rep. 2005 Jul; 6(4):271-5. Huckabay C, Nitti VW. PMID: 15978226.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    143. Overactive bladder: achieving a differential diagnosis from other lower urinary tract conditions. Int J Clin Pract. 2005 Jul; 59(7):825-30. Nitti V, Taneja S. PMID: 15963211.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    144. Patient perception of videourodynamic testing: a questionnaire based study. J Urol. 2005 Feb; 173(2):555-9. Scarpero HM, Padmanabhan P, Xue X, Nitti VW. PMID: 15643252.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    145. Correlation of abdominal leak point pressure with objective incontinence severity in men with post-radical prostatectomy stress incontinence. Neurourol Urodyn. 2005; 24(3):207-10. Twiss C, Fleischmann N, Nitti VW. PMID: 15791628.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    146. Primary bladder neck obstruction in men and women. Rev Urol. 2005; 7 Suppl 8:S12-7. Nitti VW. PMID: 16985885; PMCID: PMC1477631.
      View in: PubMed   Mentions: 18  
    147. Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol. 2005; 7 Suppl 6:S14-21. Nitti VW. PMID: 16986024; PMCID: PMC1477621.
      View in: PubMed   Mentions: 75  
    148. Is There a Role for alpha-Blockers for the Treatment of Voiding Dysfunction Unrelated to Benign Prostatic Hyperplasia? Rev Urol. 2005; 7 Suppl 4:S49-55. Nitti VW. PMID: 16986055; PMCID: PMC1477610.
      View in: PubMed   Mentions: 4  
    149. A urodynamics protocol to optimally assess men with post-prostatectomy incontinence. Neurourol Urodyn. 2005; 24(7):622-6. Huckabay C, Twiss C, Berger A, Nitti VW. PMID: 16208638.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    150. Pelvic floor reconstruction: state-of-the-art and beyond. Urol Clin North Am. 2004 Nov; 31(4):757-67. Fleischmann NB, Nitti VW. PMID: 15474603.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    151. Voiding dysfunction in young, nulliparous women: symptoms and urodynamic findings. Int Urogynecol J Pelvic Floor Dysfunct. 2004 Nov-Dec; 15(6):373-7; discussion 377. Rosenblum N, Scarpero HM, Nitti VW. PMID: 15278258.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    152. Duloxetine: a new pharmacologic therapy for stress urinary incontinence. Rev Urol. 2004; 6 Suppl 3:S48-55. Nitti VW. PMID: 16985864; PMCID: PMC1472858.
      View in: PubMed   Mentions: 1  
    153. Degree of bother caused by nocturia in women. Neurourol Urodyn. 2004; 23(2):130-3. Fiske J, Scarpero HM, Xue X, Nitti VW. PMID: 14983424.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    154. An artificial somatic-central nervous system-autonomic reflex pathway for controllable micturition after spinal cord injury: preliminary results in 15 patients. J Urol. 2003 Oct; 170(4 Pt 1):1237-41. Xiao CG, Du MX, Dai C, Li B, Nitti VW, de Groat WC. PMID: 14501733.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    155. Management of obstructive voiding dysfunction after incontinence surgery: lessons learned. Urology. 2003 Sep; 62(3):391-9. Gomelsky A, Nitti VW, Dmochowski RR. PMID: 12946730.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    156. Recent advances in management of female lower urinary tract trauma. Curr Opin Urol. 2003 Jul; 13(4):279-84. Hartanto VH, Nitti VW. PMID: 12811291.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    157. Endoscopic evacuation of Durasphere. Urology. 2003 Jul; 62(1):135-7. Hartanto VH, Lightner DJ, Nitti VW. PMID: 12837442.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    158. Vaginal granulation tissue secondary to bone anchors: experience in two patients. J Urol. 2003 Jun; 169(6):2300-1. Stember DS, Scarpero HM, Nitti VW. PMID: 12771779.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    159. American Urological Association Symptom Index for lower urinary tract symptoms in women: correlation with degree of bother and impact on quality of life. Urology. 2003 Jun; 61(6):1118-22. Scarpero HM, Fiske J, Xue X, Nitti VW. PMID: 12809877.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansPHPublic Health
    160. Repeat urethrolysis after failed urethrolysis for iatrogenic obstruction. J Urol. 2003 Mar; 169(3):1013-6. Scarpero HM, Dmochowski RR, Nitti VW. PMID: 12576834.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    161. Transdermal therapy for overactive bladder: present and future. Rev Urol. 2003; 5 Suppl 8:S31-6. Nitti VW. PMID: 16985988; PMCID: PMC1502392.
      View in: PubMed   Mentions:
    162. Pubovaginal sling and pelvic prolapse repair in women with occult stress urinary incontinence: effect on postoperative emptying and voiding symptoms. Urology. 2002 Jun; 59(6):856-60. Barnes NM, Dmochowski RR, Park R, Nitti VW. PMID: 12031368.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    163. Early results of pubovaginal sling lysis by midline sling incision. Urology. 2002 Jan; 59(1):47-51; discussion 51-2. Nitti VW, Carlson KV, Blaivas JG, Dmochowski RR. PMID: 11796279.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    164. Clinical impact of overactive bladder. Rev Urol. 2002; 4 Suppl 4:S2-6. Nitti VW. PMID: 16986018; PMCID: PMC1476019.
      View in: PubMed   Mentions: 7  
    165. Bladder outlet obstruction in women: prevalence, recognition, and management. Curr Urol Rep. 2001 Oct; 2(5):379-87. Patel R, Nitti V. PMID: 12084245.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    166. Post-urethral suspension obstruction. Curr Opin Urol. 2001 Jul; 11(4):411-6. Rosenblum N, Nitti VW. PMID: 11429503.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    167. Improving conservative treatment of overactive bladder and urge incontinence--1 small step at a time. J Urol. 2001 Jul; 166(1):150-1. Nitti VW. PMID: 11435844.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    168. Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol. 2001 Apr; 165(4):1193-8. Govier FE, Litwiller S, Nitti V, Kreder KJ, Rosenblatt P. PMID: 11257669.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    169. The prevalence of urinary incontinence. Rev Urol. 2001; 3 Suppl 1:S2-6. Nitti VW. PMID: 16985992; PMCID: PMC1476070.
      View in: PubMed   Mentions: 36  
    170. Dysfunctional voiding in women. J Urol. 2001 Jan; 165(1):143-7; discussion 147-8. Carlson KV, Rome S, Nitti VW. PMID: 11125384.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    171. Value of routine evaluation of the voiding phase when performing urodynamic testing in women with lower urinary tract symptoms. J Urol. 2000 Nov; 164(5):1614-8. Carlson KV, Fiske J, Nitti VW. PMID: 11025717.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    172. Erosion of woven polyester pubovaginal sling. J Urol. 1999 Dec; 162(6):2070-2. Kobashi KC, Dmochowski R, Mee SL, Mostwin J, Nitti VW, Zimmern PE, Leach GE. PMID: 10569572.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    173. Diagnosing bladder outlet obstruction in women. J Urol. 1999 May; 161(5):1535-40. Nitti VW, Tu LM, Gitlin J. PMID: 10210391.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    174. Evaluation of the female with neurogenic voiding dysfunction. Int Urogynecol J Pelvic Floor Dysfunct. 1999; 10(2):119-29. Nitti VW. PMID: 10384975.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    175. The etiology of post-radical prostatectomy incontinence and correlation of symptoms with urodynamic findings. J Urol. 1998 Oct; 160(4):1317-20. Ficazzola MA, Nitti VW. PMID: 9751344.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    176. Total vaginal prolapse with multiple vesical calculi after hysterectomy. J Urol. 1998 Mar; 159(3):983. Nieder AM, Chun TY, Nitti VW. PMID: 9474200.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    177. The management of unilateral poorly functioning kidneys in patients with posterior urethral valves. J Urol. 1997 Sep; 158(3 Pt 2):1001-3. Kim YH, Horowitz M, Combs AJ, Nitti VW, Glassberg KI. PMID: 9258129.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    178. Management of posterior urethral valves on the basis of urodynamic findings. J Urol. 1997 Sep; 158(3 Pt 2):1011-6. Kim YH, Horowitz M, Combs AJ, Nitti VW, Borer J, Glassberg KI. PMID: 9258132.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    179. Periurethral collagen injection for the treatment of urinary incontinence in children. J Urol. 1997 Jun; 157(6):2303-5. Chernoff A, Horowitz M, Combs A, Libretti D, Nitti V, Glassberg KI. PMID: 9146659.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    180. Voiding dysfunction following transurethral resection of the prostate: symptoms and urodynamic findings. J Urol. 1997 Feb; 157(2):600-3. Nitti VW, Kim Y, Combs AJ. PMID: 8996367.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    181. Comparative urodynamic findings after primary valve ablation, vesicostomy or proximal diversion. J Urol. 1996 Aug; 156(2 Pt 2):673-6. Kim YH, Horowitz M, Combs A, Nitti VW, Libretti D, Glassberg KI. PMID: 8683757.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    182. A new method using neuromagnetic stimulation to measure conduction time within the cauda equina. Electroencephalogr Clin Neurophysiol. 1996 Apr; 101(2):153-66. Maccabee PJ, Lipitz ME, Desudchit T, Golub RW, Nitti VW, Bania JP, Willer JA, Cracco RQ, Cadwell J, Hotson GC, Eberle LP, Amassian VE. PMID: 8647020.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    183. The role of clinical research in the diagnosis and treatment of urinary incontinence. J Urol. 1996 Apr; 155(4):1268-9. Nitti VW. PMID: 8632548.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    184. Primary care practitioners: an analysis of their perceptions of voiding dysfunction and prostate cancer. J Urol. 1996 Feb; 155(2):601-4. Plawker MW, Fleisher JM, Nitti VW, Macchia RJ. PMID: 8558669.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    185. The role of urodynamics in the evaluation of voiding dysfunction in men after cerebrovascular accident. J Urol. 1996 Jan; 155(1):263-6. Nitti VW, Adler H, Combs AJ. PMID: 7490851.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    186. Correlation of Valsalva leak point pressure with subjective degree of stress urinary incontinence in women. J Urol. 1996 Jan; 155(1):281-5. Nitti VW, Combs AJ. PMID: 7490856.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    187. Urology. Controversies old and new. Lancet. 1995 Dec 23-30; 346 Suppl:s26. Nitti VW, Lepor H. PMID: 9454044.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    188. Mixed gonadal dysgenesis and dysgenetic male pseudohermaphroditism. J Urol. 1995 Apr; 153(4):1267-73. Borer JG, Nitti VW, Glassberg KI. PMID: 7869527.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    189. Significance of rectal contractions noted on multichannel urodynamics. Neurourol Urodyn. 1995; 14(1):73-80. Combs AJ, Nitti VW. PMID: 7742852.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    190. Penectomy in diabetic patients undergoing maintenance dialysis. Am J Nephrol. 1995; 15(2):152-6. Bali I, Abdu AF, Gloster ES, Nitti VW, Friedman EA. PMID: 7733153.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    191. Obstruction following anti-incontinence procedures: diagnosis and treatment with transvaginal urethrolysis. J Urol. 1994 Jul; 152(1):93-8. Nitti VW, Raz S. PMID: 8201698.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    192. Intravesical capsaicin for treatment of neurogenic bladder. Lancet. 1994 Jun 11; 343(8911):1448. Nitti VW. PMID: 7911174.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    193. Correlation of the AUA symptom index with urodynamics in patients with suspected benign prostatic hyperplasia. Neurourol Urodyn. 1994; 13(5):521-7; discussion 527-9. Nitti VW, Kim Y, Combs AJ. PMID: 7530554.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    194. Ice-water test in urodynamic assessment. Lancet. 1993 Oct 30; 342(8879):1066-7. Nitti VW. PMID: 8105305.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    195. Transvaginal repair of vesicovaginal fistula using a peritoneal flap. J Urol. 1993 Jul; 150(1):56-9. Raz S, Bregg KJ, Nitti VW, Sussman E. PMID: 8510275.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    196. The Raz bladder neck suspension in patients 65 years old and older. J Urol. 1993 Apr; 149(4):802-7. Nitti VW, Bregg KJ, Sussman EM, Raz S. PMID: 8455244.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    197. Transvaginal repair of enterocele. J Urol. 1993 Apr; 149(4):724-30. Raz S, Nitti VW, Bregg KJ. PMID: 8455231.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    198. The Raz bladder neck suspension: results in 206 patients. J Urol. 1992 Sep; 148(3):845-50. Raz S, Sussman EM, Erickson DB, Bregg KJ, Nitti VW. PMID: 1512837.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    199. Bladder cancer in geriatric patients. Alternatives to radical cystectomy. Clin Geriatr Med. 1990 Feb; 6(1):173-84. Nitti VW, Macchia RJ. PMID: 2405977.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    200. [Ceftizoxime and its place in the context of modern cephalosporins]. Clin Ter. 1986 May 15; 117(3):233-60. Nitti V. PMID: 3524975.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    201. [Evaluation of multivariate statistical analysis in the use of markers for the differential diagnosis between bronchopneumopathies and lung tumors]. Recenti Prog Med. 1985 Dec; 76(12):629-34. Virgilio R, Nitti V, Corsi G, Adorno V, Zofra S, Iepparelli G, Valentino B, Valentino D, Vigorito F. PMID: 3832203.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    202. Pharmacokinetic study of intravenous rifampicin. Chemotherapy. 1977; 23(1):1-6. Nitti V, Virgilio R, Patricolo MR, Iuliano A. PMID: 832508.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    203. [Primary resistance of mycobacterium tuberculosis (studies related to the triennium 1973-6)]. Arch Monaldi. 1977 Jan-Apr; 32(1-2):29-39. Nitti V, Iuliano A. PMID: 417694.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    204. [Epidemiological survey of chronic bronchitis in the city of Napels with special reference to the role and possible interaction of various exogenous factors]. Bull Int Union Tuberc. 1976; 51(1 Pt 2):685-99. Nitti V, de Michele G, Famiglietti B, Miniccuci E, Ortolani G, Sessa T, Lauro N. PMID: 1052916.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    205. [Exogenous factors related to chronic bronchitis as determined by multi-center studies in the city of Naples. Presentation and interpretation of the results]. Arch Monaldi. 1975 Mar-Apr; 30(2):148-59. Nitti V, De Michele G. PMID: 1225233.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    206. [The place of intermittent treatment in the current framework of antitubercular chemotherapy]. Arch Monaldi. 1974 May-Aug; 29(3-4):314-25. Nitti V, Delli Veneri F. PMID: 4463916.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    207. Studies on blood serum levels of rifampicin in patients with normal and impaired liver function. Chemotherapy. 1973 Oct; 19(4):197-205. Curci G, Claar E, Bergamini N, Ninni A, Claar GM, Ascione A, Nitti V. PMID: 4772959.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    208. Comparative investigations of the enzyme-inducing activity of rifampicin and barbiturates in man. Chemotherapy. 1973 Oct; 19(4):206-10. Nitti V, Ninni A, Meola G, Iuliano A, Curci G. PMID: 4772960.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    209. [Intermittent therapy in tuberculosis]. Recenti Prog Med. 1973 Jul; 55(1):55-92. Nitti V, Delli Veneri F, Ninni A, Marsico SA. PMID: 4800779.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    210. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects. Scand J Respir Dis Suppl. 1973; 84:180-5. Nitti V. PMID: 4593266.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    211. [Primary resistance of Mycobacterium tuberculosis. Bacteriological and epidemiological aspects]. Arch Monaldi. 1972 Jul-Aug; 27(4):454-74. Nitti V. PMID: 4217601.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    212. Antituberculosis activity of rifampin. Report of studies performed and in progress (1966-1971). Chest. 1972 Jun; 61(6):589-98. Nitti V. PMID: 4624281.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    213. Half-life of rifampicin after repeated administration of different doses in humans. Chemotherapy. 1972; 17(6):373-81. Curci G, Bergamini N, Delli Veneri F, Ninni A, Nitti V. PMID: 5082603.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    214. Rifampicin blood serum levels and half-life during prolonged administration in tuberculous patients. Chemotherapy. 1972; 17(2):121-9. Nitti V, Delli Veneri F, Ninni A, Meola G. PMID: 4558400.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    215. [Problems and prospects of antitubercular drug therapy at the present time]. Rev Bras Med. 1971 Aug; 28(8):431-5. Nitti V. PMID: 5136037.
      View in: PubMed   Mentions: Translation:Humans
    216. [Trends in the general therapy of chronic aspecific bronchopneumopathies]. Arch Monaldi. 1971 May-Jan; 26(3):203-16. Nitti V. PMID: 5145194.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    217. [Influence of immunity on the action of various tuberculostatic drugs]. Ftiziologia. 1971 May-Jun; 20(3):239-44. Nitti V. PMID: 5164059.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    218. [On the role of the macroorganism in the appearance of bacillary resistance]. Ftiziologia. 1971 May-Jun; 20(3):245-8. Nitti V. PMID: 5005958.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    219. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis. Am Rev Respir Dis. 1971 Mar; 103(3):329-37. Nitti V, Catena E, Delli Veneri F, De Michele G, Marra A. PMID: 5005040.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    220. Results and tolerance of prolonged rifampicin treatment in recent and chronic forms of pulmonary tuberculosis. Respiration. 1971; 28:Suppl:57-69. Nitti V. PMID: 4948629.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    221. [Kinetic rate constant changes of Rifampicin and bilirubin serum levels following single and repeated administration of different per kg doses in humans]. Arch Monaldi. 1970 Nov-Dec; 25(6):427-40. Curci G, Bergamini N, Delli Veneri F, Ninni A, Nitti V. PMID: 5514802.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    222. [Behavior of blood levels of rifampicin during the course of treatment]. Arch Monaldi. 1970 Jul-Aug; 25(4):310-20. Nitti V, Delli Veneri F, Ninni A, Meola G. PMID: 4949912.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    223. Rifampicin in the treatment of pulmonary tuberculosis. Bull Int Union Tuberc. 1970 Jun; 43:57-9. Nitti V. PMID: 5425575.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    224. [Problems and prospects of antitubercular chemotherapy at the present time]. Arch Monaldi. 1970 Mar-Apr; 25(2):115-26. Nitti V. PMID: 5510341.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    225. Experimental and clinical studies on the antituberculous activity of rifampicin alone or combined with other drugs. Antibiot Chemother. 1970; 16:444-70. Nitti V. PMID: 5002308.
      View in: PubMed   Mentions: 1  Translation:HumansAnimalsCells
    226. [Intermittent treatment with Rifampicin in experimental tuberculosis in guinea pigs]. Arch Tisiol Mal Appar Respir. 1969 Dec; 24(12):923-43. Nitti V, Ninni A, Marsico SA. PMID: 5312739.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    227. [Activity of terizidone in experimental tuberculosis in rabbits]. Arch Tisiol Mal Appar Respir. 1969 Sep; 24(9):667-98. Nitti V, Catena E, Ninni A, Marsico SA. PMID: 5315045.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    228. [Activity of rifampicin in the treatment of pulmonary tuberculosis]. Arch Tisiol Mal Appar Respir. 1969 Jun; 24(6):453-93. Nitti V. PMID: 5315095.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    229. [Rifomycin in treatment of chronic tuberculosis with bacilli resistant to standard medications]. Acta Tuberc Pneumol Belg. 1969; 60(3):455-65. Nitti V, Delli Veneri F, Marra A. PMID: 4906100.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    230. In vivo bactericidal activity of rifampicin in combination with other antimycobacterial agents. Chemotherapy. 1969; 14(6):356-65. Nitti V, Ninni A. PMID: 4983709.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    231. [Case report of a pleuro-pneumonic acute process of Pseudomonas aeruginosa, treated with gentamicin]. G Ital Chemioter. 1969 Jan-Sep; 16(1):199-201. Nitti V, Delli Veneri F, Centrella G. PMID: 4998302.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    232. [The determination of mycobacterial resistance to Rifampicin with the proportion method. (Technical problems and definition of the critical levels)]. Arch Tisiol Mal Appar Respir. 1968 Dec; 23(12):979-1000. Nitti V, Ninni A, Iodice F. PMID: 4977268.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    233. [Endogenous reinfection and exogenous reinfection in tubercular pathology]. Arch Tisiol Mal Appar Respir. 1968 Aug; 23(8):638-48. Nitti V. PMID: 4973804.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    234. [Rifampicin in tuberculosis. Summary of the observations and discussion]. Arch Tisiol Mal Appar Respir. 1968 Jun; 23(6):487-96. Nitti V. PMID: 5309062.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    235. [Rifamicin in the studies of the Scuola Tisiologica in Naples]. Arch Tisiol Mal Appar Respir. 1968 Apr; 23(4):271-92. Nitti V. PMID: 4981409.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    236. [On the bactericidal activity in vivo of Rifampicin alone or associated with isoniazid]. Arch Tisiol Mal Appar Respir. 1967 Oct; 22(10):859-70. Nitti V, Ninni A, Natali P. PMID: 4975183.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    237. [Activity of Rifampicin associated with other drugs on experimental tuberculosis in guinea pigs]. Arch Tisiol Mal Appar Respir. 1967 Oct; 22(10):871-95. Nitti V, Ninni A. PMID: 5304754.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    238. [Primary mycobacterial resistance and its relations to the clinical aspects and therapy of tuberculosis]. Arch Tisiol Mal Appar Respir. 1967 Jun; 22(6):519-34. Nitti V. PMID: 4973216.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    239. [The activity of Rifampicin in vitro on atypical mycobacteria]. Arch Tisiol Mal Appar Respir. 1967 May; 22(5):498-506. Nitti V. PMID: 4975206.
      View in: PubMed   Mentions: 1     Fields:    Translation:Cells
    240. [Therapeutic activity of the Rifampicin in pulmonary tuberculosis]. Arch Tisiol Mal Appar Respir. 1967 May; 22(5):417-62. Nitti V, Catena E, Bariffi F, Delli Veneri F. PMID: 5304770.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    241. Activity of rifampicin in experimental tuberculosis of the guinea pig. Chemotherapy. 1967; 12(6):369-400. Nitti V, Catena E, Ninni A, Di Filippo A. PMID: 4968843.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    242. [Experimental studies of the antimycobacterial activity of Rifampicine]. Arch Tisiol Mal Appar Respir. 1966 Nov; 21(11):867-910. Nitti V, Catena E, Ninni A, Di Filippo A. PMID: 4969274.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    243. [The antimycobacterial activity of rifamycin B diethylamide]. Arch Tisiol Mal Appar Respir. 1966 May; 21(5):359-69. Nitti V, Ninni A, Centrella G. PMID: 5297199.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    244. The antituberculous activity of rifamycin SV. Helv Med Acta. 1965 Dec; 32(6):603-24. Nitti V. PMID: 4958120.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    245. [Pulmonary tuberculosis in advanced age. Causes of death and anatomopathologic pictures]. Riv Anat Patol Oncol. 1965 Mar-Apr; 27(3):312-49. Nitti V, Catena E, Tanzi PL, Ninni A. PMID: 5886063.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    246. [ACTIVITY OF 4-4' DIISOAMYLOXYTHIOCARBANILIDE ON EXPERIMENTAL TUBERCULOSIS OF THE GUINEA PIG]. Arch Tisiol Mal Appar Respir. 1964 Nov; 19:859-88. NITTI V, CATENA E, NINNI A. PMID: 14339285.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    247. [INFLUENCE OF THE STATE OF BACTERIAL AGGREGATION ON THE ACTIVITY OF RIFOMYCIN SV IN VITRO]. Arch Tisiol Mal Appar Respir. 1963 Jun; 18:594-600. NITTI V. PMID: 14072544.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    248. [ANTI-MYCOBACTERIAL ACTIVITY OF RIFOMYCIN SV IN GUINEA PIGS]. Arch Tisiol Mal Appar Respir. 1963 Jun; 18:601-12. NITTI V, NINNI A. PMID: 14072545.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    249. [ON THE ANTITUBERCULAR ACTIVITY OF ETHIONAMIDE]. G Ital Chemioter. 1963 Apr-Jun; 10:151-5. NITTI V. PMID: 14074253.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    250. [Antimycobacterial activity of rifamycin SV in vitro]. Arch Tisiol Mal Appar Respir. 1963 Mar; 18:177-89. NITTI V. PMID: 13938848.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    251. [Modifications of the bacteriologic findings in tuberculotics subjected to treatment with rifamycin SV]. Arch Tisiol Mal Appar Respir. 1963 Mar; 18:269-80. NITTI V, VIRGILIO R, NINNI A. PMID: 13938849.
      View in: PubMed   Mentions:    Fields:    
    252. [THE ROUTES AND METHODS OF ADMINISTRATION OF RIFAMYCIN SV. THE TOLERANCE OF THE BODY]. Chemotherapia (Basel). 1963; 12:482-91. NITTI V. PMID: 14185774.
      View in: PubMed   Mentions:
    253. [The determinism of allergy in tuberculosis. (Experimental data)]. Arch Tisiol Mal Appar Respir. 1962 Nov; 17:850-61. NITTI V. PMID: 13938847.
      View in: PubMed   Mentions:    Fields:    
    254. [The resistance of Mycobacterium tuberculosis to rifamycin SV]. Arch Tisiol Mal Appar Respir. 1962 May; 17:357-73. NITTI V, NINNI A. PMID: 14480073.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    255. [Activity of rifomycin SV on mycobacteria in vitro]. Arch Tisiol Mal Appar Respir. 1961 Dec; 16:1023-78. NITTI V, VIRGILIO R, NINNI A. PMID: 14480074.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    256. [Contribution to the knowledge of biologically incapsulated post-pleuritic empyema]. Arch Tisiol Mal Appar Respir. 1961 Jun; 16:485-506. NITTI V, MIRAGLIA E, ANZANO O. PMID: 13729296.
      View in: PubMed   Mentions:    Fields:    
    257. [Rifomycin SV: a new antibiotic against Mycobacterium tuberculosis. Prelimnary note]. Arch Tisiol Mal Appar Respir. 1961 May; 16:361-73. MONALDI V, CURCI G, NITTI V. PMID: 13771953.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    258. [Considerations on current epidemiological and clinical aspects and on therapeutic problems of tuberculosis when first detected]. Lotta Tuberc. 1961 May; 31:433-6. NITTI V. PMID: 14480075.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    259. [Morpho-structural aspects of Mycobacterium tuberculosis under the action of various anti-bacterial drugs]. Arch Tisiol Mal Appar Respir. 1961 Apr; 16:349-58. NITTI V, VIRGILIO R. PMID: 13729299.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    260. [On the audiotoxic activity of dihydrostreptomycin (audiometric and statistical observations)]. Arch Tisiol Mal Appar Respir. 1961 Feb; 16:141-59. CURCI G, DE VITA C, NITTI V, PERRELLA F, ANZANO O, NINNI A. PMID: 13882673.
      View in: PubMed   Mentions:    Fields:    
    261. [Observations on the morphology of tubercular mycobacteria studied by the electron microscope]. Arch Tisiol Mal Appar Respir. 1960 Nov; 15:1076-85. NITTI V, VIRGILIO R. PMID: 13729300.
      View in: PubMed   Mentions: 1     Fields:    Translation:Cells
    262. [Observations on the therapeutic activity of ethioniamide]. Arch Tisiol Mal Appar Respir. 1960 Oct; 15:971-95. NITTI V, MIRAGLIA E, VIRGILIO R. PMID: 13729297.
      View in: PubMed   Mentions:    Fields:    
    263. [Action of discontinuous contact with kanamycin on Mycobacterium tuberculosis in vitro]. Riv Ist Sieroter Ital. 1960 Sep-Oct; 35:556-63. NITTI V, CANTARELLA R. PMID: 13729295.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    264. [Action of the thioamide of alpha-ethylisonicotinic acid on the morphology of Mycobacterium tuberculosis (research by electron microscopy)]. Riv Ist Sieroter Ital. 1960 Sep-Oct; 35:515-28. NITTI V, VIRGILIO R. PMID: 13729298.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    265. [Mechanism of action "in vivo" of isoniazid in the findings of the Naples school]. Arch Tisiol Mal Appar Respir. 1960 Aug; 15:797-808. CURCI G, NITTI V. PMID: 13718886.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    266. [The activity of kanamycin on the growth curve of Mycobacterium tuberculosis. Note 2. Action of kanamycin associated with other antibacterial agents]. G Clin Med. 1960 Mar; 41:326-44. NITTI V, VIRGILIO R. PMID: 14427379.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    267. [On the reentrance of former tuberculotics into the working life. (Observations on trends in the field)]. Arch Tisiol Mal Appar Respir. 1960 Mar; 15:255-9. D'ALFONSO G, NITTI V. PMID: 13719133.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    268. [The action of kanamycin on the growth curve of Mycobacterium tuberculosis. Note 1. Activity of kanamycin alone]. G Clin Med. 1960 Feb; 41:249-61. NITTI V, VIRGILIO R. PMID: 14427378.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    269. [On some pictures of malformative bronchopneumopathy due to anatomic defect. (Radiological and clinical study)]. Arch Tisiol Mal Appar Respir. 1959 Nov; 14:1077-106. NITTI V, MIRAGLIA E. PMID: 14427375.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    270. [In vitro bactericidal activity of alpha-ethyl-isonicotinic acid thioamide]. Riv Ist Sieroter Ital. 1959 Sep-Oct; 34:373-81. NITTI V, MEOLA G. PMID: 14427374.
      View in: PubMed   Mentions:    Fields:    
    271. [Recent acquisitions on bacterial cytology in the light of electron microscopy, with special reference to mycobacterial]. Arch Tisiol Mal Appar Respir. 1959 Sep; 14:239-56. NITTI V, VIRGILIO R. PMID: 14427377.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    272. [The thioamide of 2-ethylisonicotinic acid and its antimycobacterial activity in vitro]. Arch Tisiol Mal Appar Respir. 1959 Aug; 14:819-42. NITTI V. PMID: 14427380.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    273. [The bacterial chemoresistance at the time of admission]. Arch Tisiol Mal Appar Respir. 1959 Jul; 14:647-61. NITTI V, PARRELLA M, CANTARELLA R. PMID: 14427376.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    274. [Behavior of chemoresistant Mycobacterium tuberculosis in the chest of the living organism]. Gazz Med Ital. 1959 Apr; 118(4):131-4. NITTI V. PMID: 13664045.
      View in: PubMed   Mentions: Translation:HumansCells
    275. [Effects of kanamycin on the morphology of Mycobacterium tuberculosis; preliminary electron microscope data]. Arch Tisiol Mal Appar Respir. 1959 Jan; 14(1):3-29. NITTI V, VIRGILIO R. PMID: 13650963.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    276. [Bactericidal activity of kanamycin on Mycobacterium tuberculosis in vitro]. Arch Tisiol Mal Appar Respir. 1959 Jan; 14(1):37-49. NITTI V. PMID: 13650965.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    277. [Mechanism of action of antitubercular chemotherapy according to the concepts of Phthisiological School of Naples]. Poumon Coeur. 1957 Jun; 13(6):526-38. NITTI V, CURCI G. PMID: 13453065.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    278. [Bactericidal effect of cycloserine in vitro]. Arch Tisiol Mal Appar Respir. 1957 Jan; 12(1):42-9. NITTI V, TANZI PL. PMID: 13436222.
      View in: PubMed   Mentions:    Fields:    
    279. [In vitro resistance of Mycobacterium tuberculosis to cycloserine]. Arch Tisiol Mal Appar Respir. 1957 Jan; 12(1):71-80. NITTI V, TSUKAMURA M. PMID: 13436225.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    280. [Therapeutic pneumothorax in physiomechanical equilibrium: bronchospirometric and ergometric aspects]. Arch Tisiol Mal Appar Respir. 1956 Aug; 11(8):602-10. MARRA A, NITTI V. PMID: 13382570.
      View in: PubMed   Mentions:    Fields:    
    281. [General aspects of chemoresistance of Mycobacterium tuberculosis and its relation to pathology and therapy]. Arch Tisiol Mal Appar Respir. 1955 Mar; 10(3):223-65. NITTI V, CURCI G. PMID: 14389070.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    282. [Qualitative aspects and chronological order of tuberculous manifestations in vaccinated subjects; clinical and bibliographical study]. Arch Tisiol Mal Appar Respir. 1955 Jan; 10(1):9-21. NITTI V, SCOZIA A. PMID: 14377856.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    283. [Conditions and methods of appearance of reinfection in vaccination subjects]. Arch Tisiol Mal Appar Respir. 1955 Jan; 10(1):121-3. NITTI V, D'ALFONSO G. PMID: 14377870.
      View in: PubMed   Mentions:    Fields:    Translation:CellsPHPublic Health
    284. [Chemoresistance of Mycobacterium tuberculosis; general aspects and relation to clinical manifestations and therapy; immunity and allergy in antibacterial-treated tuberculosis]. G Ital Chemioter. 1954 Jul-Dec; 1(3-4):390-421. NITTI V, CURCI G. PMID: 14391652.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    285. [The relation between resistance to isoniazid and resistance to other antibiotic compounds]. Arch Tisiol Mal Appar Respir. 1954 Feb; 9(2):98-105. NITTI V, DE ASCENTIS U. PMID: 13159624.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    286. [Isoniazid in the light of laboratory findings]. Arch Tisiol Mal Appar Respir. 1953 Nov; 8(11):859-916. NITTI V, CURCI G. PMID: 13139951.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    287. [Laboratory investigations of isoniazid]. Minerva Med. 1953 Oct 20; 44(84):1132-3. NITTI V, CURCI G. PMID: 13119539.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    288. [Isoniazid in the light of laboratory findings]. Lotta Tuberc. 1953 Oct-Nov; 23(10-11):848-52. NITTI V, CURCI G. PMID: 13153273.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    289. [Aspects and situation of osteoarticular localization of miliary tuberculosis]. Arch Tisiol Mal Appar Respir. 1953 Jun; 8(6):448-75. PACINI D, NITTI V. PMID: 13105518.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    290. [Dubos' cytochemical reaction for the differentiation of virulent and avirulent mycobacteria; technical considerations and results]. Arch Tisiol Mal Appar Respir. 1953 May; 8(5):360-77. NITTI V, TALIERCIO E. PMID: 13093310.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    291. [Effect of culture filtrates on activity of isonicotinic acid hydrazide in vitro]. Arch Tisiol Mal Appar Respir. 1953 Mar; 8(3):201-5. NITTI V, CURCI G. PMID: 13058743.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    292. [Virulence of PAS resistant Mycobacterium tuberculosis]. Arch Tisiol Mal Appar Respir. 1952 Dec; 7(12):974-80. NITTI V, TALIERCIO E. PMID: 13041536.
      View in: PubMed   Mentions: 1     Fields:    Translation:Cells
    293. [So-called secondary therapeutic effects of isonicotinic acid hydrazide; experimental studies with isonicotinic acid hydrazide resistant bacteria]. Arch Tisiol Mal Appar Respir. 1952 Nov; 7(11):927-30. CURCI G, NITTI V. PMID: 13031868.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    294. [Resistance of Mycobacterium tuberculosis to isonicotinic acid hydrazide]. Arch Tisiol Mal Appar Respir. 1952 Sep; 7(9):735-43. NITTI V. PMID: 13017972.
      View in: PubMed   Mentions: 2     Fields:    Translation:Cells
    295. [Role of anal fistula in tuberculosis]. Arch Tisiol Mal Appar Respir. 1952 Jul; 7(7):540-55. NITTI V, CANTARELLA R. PMID: 13017954.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    296. [Tuberculosis pathology in the vaccinated subject]. Arch Tisiol Mal Appar Respir. 1952 Jun; 7(6):453-9. NITTI V. PMID: 13017947.
      View in: PubMed   Mentions:    Fields:    Translation:CellsPHPublic Health
    297. [Pneumonectomy in pulmonary tuberculosis]. Arch Tisiol Mal Appar Respir. 1952 May; 7(5):varia; 153-79. NITTI V, DE MARCO F, LIGUORI R. PMID: 13017930.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    298. [In vitro effect of PAB on Mycobacterium tuberculosis and M. paratuberculosis]. Boll Soc Ital Biol Sper. 1951 Dec; 27(12):1681-8. NITTI V. PMID: 14934920.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    299. [Antagonism between PAS and PAB]. Arch Tisiol Mal Appar Respir. 1951 Dec; 6(12):1091-5. NITTI V, DE FRANCISCIS V. PMID: 14924891.
      View in: PubMed   Mentions:    Fields:    
    300. [Reversibility of the bacteriostatic action of PAS]. Boll Soc Ital Biol Sper. 1951 Dec; 27(12):1679-81. NITTI V. PMID: 14934919.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    301. [Lyophilization, general aspects and application to BCG vaccine]. Arch Tisiol Mal Appar Respir. 1951 Nov; 6(11):Varia, 429-41. NITTI V. PMID: 14915783.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    302. [A new active antibiotic against Mycobacteria: viomycin]. Arch Tisiol Mal Appar Respir. 1951 Aug; 6(8):Varia, 299-304. NITTI V. PMID: 14878565.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    303. [Tuberculosis vaccination]. Rass Int Clin Ter. 1951 May 30; 31(10):320-1. MONALDI V, CURCI G, NITTI V. PMID: 14864902.
      View in: PubMed   Mentions: Translation:HumansCellsPHPublic Health
    304. [Tuberculous processes in subjects vaccinated with BCG]. Arch Tisiol Mal Appar Respir. 1951 Jan; 6(1):57-94. NITTI V. PMID: 14820591.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    305. [Effect of TB1/698 on experimental tuberculosis of the guinea pig]. G Ital Della Tuberc. 1950 Nov-Dec; 4(6):442-4. CURCI G, NITTI V. PMID: 14813493.
      View in: PubMed   Mentions: Translation:Animals
    306. [Resistance of Mycobacterium tuberculosis to p-aminosalicylic acid]. Arch Tisiol Mal Appar Respir. 1950 Sep; 5(9):765-7. NITTI V. PMID: 14791123.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    307. [Relation between pulmonary tuberculosis and osteoarticular tuberculosis. III. Osteoarticular processes in the course of pulmonary tuberculosis]. Arch Tisiol Mal Appar Respir. 1950 Jul; 5(7):595-631. PACINI D, NITTI V. PMID: 14791104.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    308. [Stability of PAS resistance in vitro and in vivo]. Boll Soc Ital Biol Sper. 1950 Jul; 26(7):1068-70. NITTI V, DE FRANCISCIS V, CANTARELLA R. PMID: 14811969.
      View in: PubMed   Mentions:    Fields:    
    309. [Effect of some vitamin factors on acquisition of streptomycin resistance by Mycobacterium tuberculosis]. Boll Soc Ital Biol Sper. 1950 Jul; 26(7):1066-8. NITTI V, MARRA A. PMID: 14811968.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    310. [Effect of PAS-resistant bacilli on activity of PAS in vitro]. Boll Soc Ital Biol Sper. 1950 Jul; 26(7):1063-5. NITTI V. PMID: 14811967.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    311. [Streptomycin resistance of Mycobacterium tuberculosis, its bacteriological characteristics and clinical reactions: critico-synthetic review]. Arch Tisiol Mal Appar Respir. 1950 May; 5(5):Varia, 178-99. NITTI V. PMID: 14777688.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    312. [Stability of PAS resistance in vitro and in vivo]. Arch Tisiol Mal Appar Respir. 1950 May; 5(5):444-52. NITTI V, DE FRANCISCIS V, CANTARELLA R. PMID: 14777692.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    313. [Reversibility of the bacteriostatic effect of streptomycin and PAS on Mycobacterium tuberculosis]. Boll Soc Ital Biol Sper. 1950 Apr; 26(4):523-4. NITTI V, DE FRANCISCIS V. PMID: 14791740.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    314. [Activity of PAS in the presence of pathological matter]. Arch Tisiol Mal Appar Respir. 1950 Apr; 5(4):350-5. NITTI V. PMID: 14777685.
      View in: PubMed   Mentions:    Fields:    
    315. [The real and practical value of the inhibition of streptomycin by certain pathological substances]. Arch Tisiol Mal Appar Respir. 1950 Feb; 5(2):148-54. CURCI G, NITTI V. PMID: 15433829.
      View in: PubMed   Mentions:    Fields:    
    316. [Hematic concentration and urinary elimination of PAS during continuous treatment]. Arch Tisiol Mal Appar Respir. 1950 Feb; 5(2):163-71. NITTI V, CURCI G. PMID: 15433831.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    317. [Acquired PAS resistance in tubercle bacilli isolated during treatment]. Arch Tisiol Mal Appar Respir. 1950 Jan; 5(1):75-80. NITTI V, DE FRANCISCIS V, CANTARELLA R. PMID: 15420047.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    318. [Streptomycin resistance in various clinical forms]. Arch Tisiol Mal Appar Respir. 1950 Jan; 5(1):69-74. NITTI V, DE FRANCISCIS V, CANTARELLA R. PMID: 15420046.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    319. [A new antitubercular drug, tuberculosis I of Domagk]. Prog Med (Napoli). 1949 Nov 15; 5(21):667. CURI G, NITTI V. PMID: 15400851.
      View in: PubMed   Mentions: Translation:Humans
    320. P-aminosalicylic acid in the treatment of tuberculosis. Prog Med (Napoli). 1949 Mar 31; 5(6):186-90. NITTI V, CURCI G. PMID: 18120996.
      View in: PubMed   Mentions:
    321. On the clinical-biological physiognomy of primary thysiogenic lobite; morphological and evolutionary aspects of morbid successions. Arch Tisiol Mal Appar Respir. 1948 Jan-Feb; 3(1):37-61. GEMMI M, NITTI V. PMID: 18861592.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    322. Methods for reactivating quiescent outbreaks. Arch Tisiol Mal Appar Respir. 1947 Sep-Oct; 2(5):466-80. NITTI V, CURCI G, DE FRANCISCIS V. PMID: 18899859.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    323. The processes with a chronic footprint in the war period. Arch Tisiol Mal Appar Respir. 1947 Sep-Oct; 2(5):481-91. NITTI V. PMID: 18899860.
      View in: PubMed   Mentions:    Fields:    
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Victor's Networks
    Concepts (552)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (12)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (59)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California